Skip to content
Review Open access

Pathogenesis of bronchopulmonary dysplasia: an immunological perspective

Oct 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 155 references
Medicine

TL;DR

It is argued that this convergence is what separates BPD from ordinary neonatal lung injury, and that the outcome depends less on the magnitude of the initiating injurious hits than on failure of the resolution program that should terminate them — a hypothesis supported by convergent preclinical evidence but not yet established in preterm infants.

Abstract

Bronchopulmonary dysplasia (BPD), the most common chronic lung disease of prematurity, is at its mechanistic core an immune-developmental disease in which inflammatory injury disrupts normal lung maturation. In the United States, BPD remains among the most common morbidities of very preterm birth, affecting a substantial proportion of infants born before 32 weeks’ gestation. These infants are born before alveolarization is complete, into an inflammatory environment that can impair ongoing lung development. This review advances a single thesis: the heterogeneous prenatal and postnatal insults that precede BPD (chorioamnionitis and the fetal inflammatory response syndrome, Ureaplasma colonization, hyperoxia, mechanical ventilation, sepsis, and intestinal dysbiosis) converge on a small number of innate sensing pathways, principally TLR2 and TLR4 signaling through NF-κB to the NLRP3 inflammasome — with parallel sterile inputs (mitochondrial reactive oxygen species and additional pattern-recognition receptors) feeding the same inflammasome node. We argue that this convergence is what separates BPD from ordinary neonatal lung injury, and that the outcome depends less on the magnitude of the initiating injurious hits than on failure of the resolution program that should terminate them — a hypothesis supported by convergent preclinical evidence but not yet established in preterm infants. Evidence is assembled across three domains: the cellular substrate (M1-skewed, classically activated–like alveolar macrophages, NETs, Th17/Treg imbalance, deficient transplacental IgG transfer); the mediator network (IL-1β, IL-6, IL-8, TNF-α, and the loss of endogenous brakes — specialized pro-resolving mediators, IL-37, Nrf2, short-chain fatty acids); and the signaling architecture (NF-κB, the NLRP3 inflammasome, and trained immunity). We also discuss the mechanistically supported, druggable nodes and the developmental phase in which each is engageable.

Read PDF

Similar papers

Review Open access Sep 2026

CLINICAL PHENOTYPES OF BRONCHOPULMONARY DYSPLASIA: IMPLICATIONS FOR DIAGNOSIS AND TREATMENT

Bronchopulmonary dysplasia (BPD) represents a highly prevalent chronic respiratory disease affecting preterm infants, frequently resulting in persistent respiratory impairment and long-term sequelae. Even among infants presenting with similar perinatal risk factors, the clinical manifestations and complications of BPD...

Анна Владимировна Меньшикова, D. Dobrianskyi · 0 citations
Review Open access Nov 2026

Bronchopulmonary Dysplasia Starts in Utero: MicroRNA Dysregulation Across the Fetal–Neonatal Continuum in the Bronchopulmonary Dysplasia Development

Bronchopulmonary dysplasia (BPD) is a heterogeneous developmental lung disorder resulting from the interaction between antenatal susceptibility and postnatal injury. Increasing evidence suggests that its biological origins may precede preterm birth, with placental dysfunction, fetal growth restriction, inflammation and...

S. Perrone, Silvia Carloni, V. Beretta et al. · 0 citations
Open access Oct 2026

Pro-inflammatory and matricellular protein expression patterns associated with bronchopulmonary dysplasia severity.

BACKGROUND Pulmonary inflammation and dysregulated repair have been linked to the development of bronchopulmonary dysplasia (BPD), but disease severity varies widely, and the mechanisms leading to BPD heterogeneity remain unclear. We hypothesized that levels of pro-inflammatory and matricellular proteins in preterm inf...

S. Essoh, Fernando A. Munoz, Lilia P. Christner et al. · 0 citations
Review Open access Sep 2026

Toward Endotype-Based Bronchopulmonary Dysplasia: Evolving Definitions and the Role of Translational Models

Bronchopulmonary dysplasia (BPD) remains one of the most frequent and clinically relevant chronic respiratory complications of extreme prematurity. Although successive definitions have improved disease classification, most are still based on oxygen requirement and respiratory support assessed at 36 weeks postmenstrual...

Marianela Rodriguez-Rey, Valeria Valez, M. Caballero et al. · 0 citations
Review Open access Nov 2026

Necrotizing enterocolitis as a disorder of neonatal mucosal immune ecology: from dysbiosis and barrier failure to regulated cell death and precision prevention

Necrotizing enterocolitis (NEC) remains one of the most severe gastrointestinal emergencies of prematurity. Although survival of extremely preterm infants has improved, NEC continues to cause substantial mortality, intestinal failure, neurodevelopmental impairment, and prolonged neonatal intensive care. Its pathogenesi...

Shao-Han Sun, Ze-Kun Yu, Mei-Mei Zhou et al. · 0 citations
Review Open access Oct 2026

The developing fetal immune landscape and congenital viral infection

Fetal development is a complex process that can lead to adverse health consequences when impaired, such as congenital anomalies, fetal growth restriction, preterm birth, and stillbirth. Although there is a well-developed literature on the timing of adaptive immune cell appearance in the fetus, comparatively little is k...

Sophia C. Chima, Sidney Sun, Tyla Duell et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.